FDA Approves Generic GLP-1 Injection for Type 2 Diabetes

The FDA has approved a low-cost generic version of liraglutide, a GLP-1 medication, offering relief to patients with Type 2 diabetes amid ongoing shortages, The Hill reported.[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.